COLOMBO NICOLETTA
Pubblicazioni
De Vitis, L., Schivardi, G., Gaeta, A., Caruso, G., Rosanu, M., Ribero, L., et al. (2025). External validation of the Annual Recurrence Risk Model (ARRM) for tailored surveillance strategy in patients with cervical cancer. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 35(6 (June 2025)) [10.1016/j.ijgc.2025.101756]. Dettaglio
Caruso, G., Gaiano, M., De Vitis, L., Stefani, E., Rosanu, M., Ribero, L., et al. (2025). Predictors of recurrence in early-stage cervical cancer without adjuvant treatment after radical surgery. EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 51(8 (August 2025)) [10.1016/j.ejso.2025.110121]. Dettaglio
Lorusso, D., Oaknin, A., Borges, G., Damian, F., Ottevanger, N., Van Gorp, T., et al. (2025). Cemiplimab plus peltopepimut-S vaccine in recurrent cervical cancer: A phase 2 clinical trial. GYNECOLOGIC ONCOLOGY, 196(May 2025), 28-35 [10.1016/j.ygyno.2025.03.019]. Dettaglio
Quesada, S., Penault-Llorca, F., Matias-Guiu, X., Banerjee, S., Barberis, M., Coleman, R., et al. (2025). Homologous recombination deficiency in ovarian cancer: Global expert consensus on testing and a comparison of companion diagnostics. EUROPEAN JOURNAL OF CANCER, 215(17 January 2025) [10.1016/j.ejca.2024.115169]. Dettaglio
Bogani, G., Moore, K., Ray-Coquard, I., Lorusso, D., Matulonis, U., Ledermann, J., et al. (2025). Incorporating immune checkpoint inhibitors in epithelial ovarian cancer. GYNECOLOGIC ONCOLOGY, 193(February 2025), 30-40 [10.1016/j.ygyno.2024.12.011]. Dettaglio